Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

Joachim Yahalom, Bouthaina Shbib Dabaja, Umberto Ricardi, Andrea Ng, N. George Mikhaeel, Ivan R. Vogelius, Tim Illidge, Shunan Qi, Andrew Wirth, Lena Specht

Blood (2020) 135 (21): 1829–1832.

https://doi.org/10.1182/blood.2020006028

Published: 2020

Includes: Supplemental data

Journal Articles

Dabaja BS, Hoppe BS, Plastaras JP, et al. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood. 2018;132(16):1635-1646.

Blood (2019) 133 (12): 1384–1385.

https://doi.org/10.1182/blood-2019-02-900738

Published: 2019

Journal Articles

Canadian Hematology Mentorship and Career Counseling Resident Survey (2015-2017)

Pauline Manuel, Jessica Petrucci, MSc, Martina Trinkaus, MD

Blood (2018) 132 (Supplement 1): 5809.

https://doi.org/10.1182/blood-2018-99-118330

Published: 2018

Journal Articles

Curative radiation for orbital MZL: how much?

Joachim Yahalom

Blood (2017) 129 (3): 270–271.

https://doi.org/10.1182/blood-2016-11-749176

Published: 2017

Journal Articles

An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy

Michael J. Kelly, MD MPH, MS, Susan K Parsons, MDMRP, David C. Hodgson, MD, Joshua T Cohen, PhD, Jennifer M Yeh, MD PhD, Jeremy S. Abramson, MD, Debra L. Friedman, MD MS, Tara O Henderson, MDMPH, Peter W Johnson, MD, Stephen G Pauker, MD, John M. Raemaekers, MD PhD, Jane N. Winter, MD, Kara M. Kelly, MD, Ralph M. Meyer, MD, Sharon M Castellino, MD, Andrew M. Evens, DO, MSc

Blood (2015) 126 (23): 2635.

https://doi.org/10.1182/blood.V126.23.2635.2635

Published: 2015

Journal Articles

Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)

Bouthaina S. Dabaja, MD, Richard Tsang, MD, Shunan Qi, Pamela Allen, PhD, David C. Hodgson, MD, Umberto Ricardi, MD, Richard T. Hoppe, MD, Andrea Ng, Lena Specht, Ye-xiong Li, MD, Stephanie Terezakis, MD, Louis Constine, MD, Joachim Yahalom, MD

Blood (2013) 122 (21): 4292.

https://doi.org/10.1182/blood.V122.21.4292.4292

Published: 2013

NARROW

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

Dabaja BS, Hoppe BS, Plastaras JP, et al. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood. 2018;132(16):1635-1646.

Canadian Hematology Mentorship and Career Counseling Resident Survey (2015-2017)

Curative radiation for orbital MZL: how much?

An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy

Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)

Email alerts

ASH Publications

American Society of Hematology

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

Dabaja BS, Hoppe BS, Plastaras JP, et al. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood. 2018;132(16):1635-1646.

Canadian Hematology Mentorship and Career Counseling Resident Survey (2015-2017)

Curative radiation for orbital MZL: how much?

An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy

Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only